Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Alteogen Inc. (196170.KQ) News - StockMarketCap

Stocks›Alteogen Inc.☆

● At closeAs of Jul 3, 2026

Alteogen Inc.

KOSDAQ: 196170✓

HealthcareBiotechnologyKOE

$218.09₩336,500.00-4.27%

$11.67BMarket cap

-P/E ratio

167.26KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$218.09₩336,500.00

-$9.72 (-4.27%) · 24h

Key metrics

Market cap$11.67B-2.19%

Enterprise value$11.67B

Volume (24h)167.26K

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding53.51M

Trading range

Previous close₩351,500.00

Day range₩331,500.00 - ₩359,000.00

52-week range-

Alteogen Inc. (196170.KQ) operates in the Biotechnology industry within the Healthcare sector, listed on KOE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news